Chunghwa Chemical Synthesis & Biotech Co., Ltd. (1762.TW)
TWD 28.8
(-1.54%)
TWD 28.8
(-1.54%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | 3.42 TWD | -43.09% |
| 2022 | 6.01 TWD | 16.25% |
| 2021 | 5.17 TWD | -24.64% |
| 2020 | 6.86 TWD | 354.3% |
| 2019 | 1.51 TWD | -50.0% |
| 2018 | 3.02 TWD | 172.07% |
| 2017 | 1.11 TWD | 42.31% |
| 2016 | 0.78 TWD | -80.4% |
| 2015 | 3.98 TWD | 1994.74% |
| 2014 | 0.19 TWD | -84.8% |
| 2013 | 1.25 TWD | -46.12% |
| 2012 | 2.32 TWD | 5.45% |
| 2011 | 2.20 TWD | -16.03% |
| 2010 | 2.62 TWD | -27.62% |
| 2009 | 3.62 TWD | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q1 | 0.52 TWD | -8.77% |
| 2024 Q2 | 0.27 TWD | -48.08% |
| 2023 Q1 | 2.31 TWD | 156.67% |
| 2023 Q4 | 0.57 TWD | 280.0% |
| 2023 Q2 | 0.38 TWD | -83.55% |
| 2023 FY | - TWD | -43.09% |
| 2023 Q3 | 0.15 TWD | -60.53% |
| 2022 Q1 | 1.65 TWD | 89.66% |
| 2022 Q4 | 0.90 TWD | -42.31% |
| 2022 Q3 | 1.56 TWD | -18.32% |
| 2022 FY | - TWD | 16.25% |
| 2022 Q2 | 1.91 TWD | 15.76% |
| 2021 Q2 | 1.63 TWD | 28.35% |
| 2021 Q3 | 1.09 TWD | -33.13% |
| 2021 FY | - TWD | -24.64% |
| 2021 Q1 | 1.27 TWD | 0.79% |
| 2021 Q4 | 0.87 TWD | -20.18% |
| 2020 Q4 | 1.26 TWD | 186.36% |
| 2020 Q3 | 0.44 TWD | -90.81% |
| 2020 Q1 | 0.36 TWD | -25.0% |
| 2020 FY | - TWD | 354.3% |
| 2020 Q2 | 4.79 TWD | 1230.56% |
| 2019 Q4 | 0.48 TWD | 45.45% |
| 2019 FY | - TWD | -50.0% |
| 2019 Q3 | 0.33 TWD | 94.12% |
| 2019 Q2 | 0.17 TWD | -67.92% |
| 2019 Q1 | 0.53 TWD | 1094.37% |
| 2018 FY | - TWD | 172.07% |
| 2018 Q3 | 2.83 TWD | 1389.47% |
| 2018 Q2 | 0.19 TWD | 280.0% |
| 2018 Q1 | 0.05 TWD | -91.8% |
| 2018 Q4 | -0.05 TWD | -101.88% |
| 2017 Q1 | -0.15 TWD | -140.54% |
| 2017 Q3 | 0.80 TWD | 600.0% |
| 2017 Q2 | -0.16 TWD | -6.67% |
| 2017 Q4 | 0.61 TWD | -23.75% |
| 2017 FY | - TWD | 42.31% |
| 2016 Q4 | 0.37 TWD | 105.56% |
| 2016 Q1 | 0.23 TWD | -71.25% |
| 2016 Q3 | 0.18 TWD | 11900.0% |
| 2016 FY | - TWD | -80.4% |
| 2016 Q2 | 0.00 TWD | -99.35% |
| 2015 Q3 | 0.41 TWD | 141.18% |
| 2015 FY | - TWD | 1994.74% |
| 2015 Q1 | 2.59 TWD | 50684.31% |
| 2015 Q2 | 0.17 TWD | -93.44% |
| 2015 Q4 | 0.80 TWD | 95.12% |
| 2014 Q2 | 0.31 TWD | 106.67% |
| 2014 Q3 | -0.28 TWD | -190.32% |
| 2014 Q1 | 0.15 TWD | 297.88% |
| 2014 FY | - TWD | -84.8% |
| 2014 Q4 | 0.01 TWD | 101.82% |
| 2013 Q1 | 0.54 TWD | 440.0% |
| 2013 FY | - TWD | -46.12% |
| 2013 Q3 | 0.09 TWD | -84.48% |
| 2013 Q4 | 0.04 TWD | -58.11% |
| 2013 Q2 | 0.58 TWD | 7.41% |
| 2012 Q2 | 1.14 TWD | 132.65% |
| 2012 FY | - TWD | 5.45% |
| 2012 Q4 | 0.10 TWD | -82.14% |
| 2012 Q3 | 0.56 TWD | -50.88% |
| 2012 Q1 | 0.49 TWD | -10.91% |
| 2011 Q2 | 0.48 TWD | -15.79% |
| 2011 Q1 | 0.57 TWD | -25.97% |
| 2011 Q3 | 0.60 TWD | 25.0% |
| 2011 FY | - TWD | -16.03% |
| 2011 Q4 | 0.55 TWD | -8.33% |
| 2010 Q1 | 0.53 TWD | 0.0% |
| 2010 FY | - TWD | -27.62% |
| 2010 Q2 | 0.60 TWD | 13.21% |
| 2010 Q4 | 0.77 TWD | 24.19% |
| 2010 Q3 | 0.62 TWD | 3.33% |
| 2009 FY | - TWD | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| Apex Biotechnology Corp. | 1.16 TWD | -194.828% |
| Sinphar Pharmaceutical Co.,Ltd. | 2.24 TWD | -52.679% |
| Panion & Bf Biotech Inc. | 0.90 TWD | -280.0% |
| GenMont Biotech Incorporation | 0.38 TWD | -800.0% |
| Abnova (Taiwan) Corporation | 0.72 TWD | -375.0% |
| Adimmune Corporation | -1.52 TWD | 325.0% |
| Tanvex BioPharma, Inc. | -16.42 TWD | 120.828% |
| Polaris Group | -2.12 TWD | 261.321% |
| Energenesis Biomedical CO.,LTD. | -3.62 TWD | 194.475% |
| UnicoCell Biomed Co., Ltd. | -1.56 TWD | 319.231% |
| PELL Bio-Med Technology Co. Ltd. | -8.62 TWD | 139.675% |